116 related articles for article (PubMed ID: 6288240)
41. [Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer].
Blossey HC; Wander HE; Nagel GA; Köbberling J; Kleeberg U
Onkologie; 1982 Aug; 5 Suppl():34-41. PubMed ID: 6290955
[TBL] [Abstract][Full Text] [Related]
42. High-dose medroxyprogesterone acetate for the treatment of advanced ovarian carcinoma.
Tropé C; Johnsson JE; Sigurdsson K; Simonsen E
Cancer Treat Rep; 1982 Jun; 66(6):1441-3. PubMed ID: 6177415
[No Abstract] [Full Text] [Related]
43. Phase II trial of bisantrene for advanced hypernephroma.
Scher H; Schwartz S; Yagoda A; Watson R; Faye L
Cancer Treat Rep; 1982 Aug; 66(8):1653-5. PubMed ID: 7105056
[No Abstract] [Full Text] [Related]
44. Hormonal therapy of renal cell carcinoma (RCC).
Bracci U; DiSilverio F; Concolino G
Prog Clin Biol Res; 1982; 100():623-40. PubMed ID: 7145993
[No Abstract] [Full Text] [Related]
45. New regimen of combination hormone therapy (ME-TA-MAP) in the treatment of advanced breast cancer. A pilot study.
Pannuti F; Martoni A; Fruet ; Marraro D; Strocchi E
Panminerva Med; 1981; 23(3):157-60. PubMed ID: 7335366
[No Abstract] [Full Text] [Related]
46. Sequential combination chemotherapy for disseminated melanoma: a Southwest Oncology Group Study.
Costanzi J; Fabian C; Wilson H; Dixon D
Cancer Treat Rep; 1981; 65(7-8):732-4. PubMed ID: 7248992
[No Abstract] [Full Text] [Related]
47. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase II Study.
Miller TP; Jones SE; Rainey JM
Cancer Treat Rep; 1983; 67(7-8):739-40. PubMed ID: 6688200
[No Abstract] [Full Text] [Related]
48. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
Fosså SD; Talle K
Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
[TBL] [Abstract][Full Text] [Related]
49. [Mistletoe therapy of metastasizing renal cancer. A phase II study].
Kjaer M
Ugeskr Laeger; 1988 Aug; 150(32):1923-8. PubMed ID: 3413875
[No Abstract] [Full Text] [Related]
50. [MAP in the treatment of adenocarcinoma of the endometrium].
Leone F; De Placido G; Frollo G
Minerva Ginecol; 1979 Apr; 31(4):251-5. PubMed ID: 460664
[No Abstract] [Full Text] [Related]
51. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
Eagan RT; Frytak S; Ingle JN; Creagan ET; Nichols WC; Kvols LK
Cancer Treat Rep; 1980; 64(8-9):925-8. PubMed ID: 7192602
[TBL] [Abstract][Full Text] [Related]
52. Phase II study of amsacrine in metastatic renal cell carcinoma: a Cancer and Leukemia Group B study.
Amrein PC; Coleman M; Richards F; Poulin RF; Berkowitz I; Kennedy BJ; Green M; Herschkopf R; Rafla S
Cancer Treat Rep; 1983 Nov; 67(11):1043-4. PubMed ID: 6688967
[No Abstract] [Full Text] [Related]
53. Treatment of the female metastatic hypernephroma.
Tucker WG
Mich Med; 1973 Aug; 72(24):525-8. PubMed ID: 4726736
[No Abstract] [Full Text] [Related]
54. [Clinovir treatment of adenocarcinoma of the uterus with lung metastases].
Stertmann WA; Hocke M; Röttger P
MMW Munch Med Wochenschr; 1983 Jul; 125(29-30):685-6. PubMed ID: 6225946
[No Abstract] [Full Text] [Related]
55. [Myelopoietic effect of medroxyprogesterone acetate at high parenteral doses in the cancer patient].
Gustavo Gercovich F; Morgenfeld E; Dragosky M; Murro H; Sorrentino M; Presman A; Martínez RE
Sangre (Barc); 1982; 27(5):883-90. PubMed ID: 7167850
[No Abstract] [Full Text] [Related]
56. [Experimental and clinical substantiation of adequate hormonal chemotherapy of kidney tumors].
Polianichko MF; Bordiushkov IuN; Smiller RR; Tiutiunova AM; Cherniavskaia GIa
Urol Nefrol (Mosk); 1978; (6):58-61. PubMed ID: 362665
[No Abstract] [Full Text] [Related]
57. Management of patients with metastatic adenocarcinoma of unknown origin: a Southwest Oncology Group study.
Shildt RA; Kennedy PS; Chen TT; Athens JW; O'Bryan RM; Balcerzak SP
Cancer Treat Rep; 1983 Jan; 67(1):77-9. PubMed ID: 6616495
[TBL] [Abstract][Full Text] [Related]
58. Cancer of the kidney: diagnostic, therapeutic, and experimental vistas. The Percy T. Magan Memorial Lecture 1973.
Kaufman JJ
Med Arts Sci; 1973; 27(3):28-38. PubMed ID: 4594800
[No Abstract] [Full Text] [Related]
59. [Therapy of metastasizing kidney cancer with hormones (androgens). A retrospective study].
Flamm J
Z Urol Nephrol; 1983 Jun; 76(6):407-11. PubMed ID: 6637169
[TBL] [Abstract][Full Text] [Related]
60. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
